Skip to main content
University of Wisconsin–Madison
UW Crest
UW Initiative to End Alzheimer's
Together, we can improve lives and build a future without Alzheimer’s disease — in Wisconsin and beyond.
  • ABOUT Expand Collapse
    • About Us
    • Leadership and Board of Visitors
    • News and Events
    • Subscribe to Our E-newsletter
    • Contact Us
  • WE SUPPORT Expand Collapse
    • Research
    • Education
    • Health Equity
  • MEMORABLE FRIENDS Expand Collapse
    • Why We Give: Featured Friends
    • Become a Memorable Friend
  • WAYS TO GIVE Expand Collapse
    • Ways to Give
    • Donate
  • DONATE
  • UW School of Medicine and Public Health
  1. Home
  2. Tag: Dementia Matters

Dementia Matters

Introducing Lecanemab, the Latest Alzheimer’s Disease Drug to Receive FDA Accelerated Approval

Posted on January 18, 2023

On the latest episode of the podcast, Dementia Matters, host Nathaniel Chin, MD, gives an overview of the new Alzheimer’s treatment Leqembi (lecanemab), and highlights results from the second and third phases of its clinical trials.

Posted in NewsTagged Dementia Matters, Dr. Nathaniel Chin, lecanemab, leqembi

Site footer content

University logo that links to main university website

Quick Links

  • About Us
  • News and Events
  • Memorable Friends
  • Donate

Contact Us

  • University of Wisconsin
    Madison, WI 53703
  • Email: iea@supportuw.org
  • Phone: (608) 308-5167
    • facebook
    • twitter
    • instagram
    • youtube

Website feedback, questions or accessibility issues: iea@medicine.wisc.edu.

Learn more about accessibility at UW–Madison.

This site was built using the UW Theme | Privacy Notice | © 2023 Board of Regents of the University of Wisconsin System.